363 KEYNOTE-042 5-year survival update: pembrolizumab versus chemotherapy in patients with previously untreated, PD-L1–positive, locally advanced or metastatic non–small-cell lung cancer

• Li Zhang,
• Kaoru Kubota,
• Yi-Long Wu,
• Byoung Chul Cho,
• Gilberto de Castro,
• Iveta Kudaba,
• Gilberto Lopes,
• Dariusz M Kowalski,
• Hande Z Turna,
• Christian Caglevic,
• Boguslawa Karaszewska,
• Konstantin K Laktionov,
• Vichien Srimuninnimit,
• Igor Bondarenko,
• Rinee Mukherjee,
• Jianxin Lin,
• Fabricio Souza,
• Tony SK Mok

Affiliations

Li Zhang

University of Macau, Taipa, Macau, China

Kaoru Kubota

Aff1 0000 0001 2173 8328grid.410821.eDepartment of Pulmonary Medicine and Oncology, Graduate School of MedicineNippon Medical School 1-1-5, Sendagi, Bunkyo-ku 113-8603 Tokyo Japan

Yi-Long Wu

6 Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China

Byoung Chul Cho

Yonsei University College of Medicine, Seoul, Republic of Korea

Gilberto de Castro

1Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil

Iveta Kudaba

2Latvian Oncology Center, Riga East Clinical University, Riga, Latvia

Gilberto Lopes

4Department of Medical Oncology, Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL, USA

Dariusz M Kowalski

5Department of Lung Cancer and Chest Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland

Hande Z Turna

6Department of Internal Medicine, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey

Christian Caglevic

7Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile

Boguslawa Karaszewska

9Przychodnia Lekarska KOMED, Konin, Poland

Konstantin K Laktionov

10Federal State Budgetary Institution “N.N. Blokhin National Medical Research Center of Oncology” of the Ministry of Health of the Russian Federation (N.N Blokhin NMRCO), Moscow, Russian Federation

Vichien Srimuninnimit

11Department of Medicine, Siriraj Hospital, Bangkok, Thailand

Igor Bondarenko

12Oncology and Medical Radiology Department, Dnipro State Medical University, Dnipro, Ukraine

Rinee Mukherjee

14Merck and Co., Inc., Kenilworth, NJ, USA

Jianxin Lin

14Merck and Co., Inc., Kenilworth, NJ, USA

Fabricio Souza

14Merck and Co., Inc., Kenilworth, NJ, USA

Tony SK Mok

15Clinical Oncology, State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong, China